Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


Tennesssee Department Of Health To Resume Administration Of Johnson & Johnson Vaccine


 

After an extensive analysis of the risks and benefits of the Janssen/Johnson & Johnson COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) voted today to recommend to the Centers for Disease Control and Prevention (CDC) that jurisdictions may resume their administration of the Janssen/Johnson & Johnson vaccine without restrictions.

The recommendation from the ACIP is unchanged from the original recommendation provided on February 27, 2021: "The Janssen COVID-19 vaccine is recommended for persons 18 years of age and older in the U.S. population under FDA's Emergency Use Authorization."

The committee made the determination after reviewing cases of rare but serious blood clots occurring in some individuals who received the vaccine. To date, 15 cases have been reported with the majority occurring in women ages 18-49 years. The risk of developing the condition is approximately 7 in 1 million vaccine doses for women in that age group. For women ages 50 years and older and for men, the risk is approximately 1 in 1 million vaccines doses.

The Tennessee Department of Health is taking necessary steps to inform all approved COVID-19 vaccine providers across the state of the information released by ACIP so that they may resume the administration of the Janssen/Johnson & Johnson vaccine as soon as possible. While the Janssen/Johnson & Johnson vaccine is in short supply, most vaccine providers in Tennessee continue to have abundant supply of the Pfizer and Moderna vaccines.

"The independent review process conducted by ACIP further shows the amount of scrutiny and review that goes into ensuring the safety of all vaccines used in this country, including those that protect against COVID-19," said Tennessee Department of Health Commissioner Lisa Piercey, MD, MBA, FAAP. "The CDC and FDA took a necessary pause in the administration of the Janssen/Johnson & Johnson vaccine and the ACIP has done its diligence to confidently recommend that the country resume its use of the vaccine. We're excited to get this third vaccine option back into use in Tennessee."

Women between the ages of 18 and 49 years should weigh the risk of the vaccine with its benefits when deciding to receive the Janssen/Johnson & Johnson vaccine versus the mRNA vaccines from Pfizer and Moderna, which have not been associated with this rare blood clotting disorder.

Individuals seeking a COVID-19 vaccine appointment can visit covid19.tn.gov or vaccinefinder.org to schedule an appointment with a local vaccine provider.

For more information regarding vaccine recommendations and guidelines from ACIP visit https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html.

The mission of the Tennessee Department of Health is to protect, promote and improve the health and prosperity of people in Tennessee. Learn more about TDH services and programs at www.tn.gov/health.

 
Share:

Related Articles:


Recent Articles

Tennessee Rare Disease Advisory Council to Inform TennCARE on Pharmaceutical Treatments

Council will advise and address impact of rare diseases on Tennesseans

Read More

Medical Groups Urge CMS to Walk Back ACO Quality Overhaul

Letter Signed by Eleven Organizations to Biden Administration

Read More

Google Chief Health Officer Dr. Karen DeSalvo Addresses Health Care Council

On behalf of the Nashville Health Care Council, Sen. Bill Frist, MD, and Google Chief Health Officer Karen DeSalvo, MD, shared a conversation on the tech company's role in healthcare.

Read More

NCI Director Updates Cancer Progress

In April, NCI Director Ned Sharpless, MD, FAACR, addressed the AACR Annual Meeting to provide an update on where we stand in the fight against cancer.

Read More

No Surprises: Federal Legislation Addresses Balance Billing

Read More

Construction, Design & Real Estate Rounds

Read More

Blakeford Expansion Focuses on Form, Function & Fun

Blakeford at Green Hills is in the midst of a major campus expansion and renovation to rethink senior living.

Read More

First-Year Data on TNPSQ Mental Health Screening Tool

An anonymous online mental health screening tool for Tennessee health professionals saw higher-than-expected s in its first year.

Read More

Acadia Healthcare CEO Discusses COVID & Mental Health

In the latest installment of the Nashville Health Care Council's Brass Tacks series, Acadia CEO Debbie Osteen discusses the toll COVID-19 has taken on mental health.

Read More

Celebrating the Annual Dr. Matthew Walker, Sr., Legacy Breakfast

The annual event, a fundraiser for the Matthew Walker Comprehensive Health Center, drew more than 340 virtual attendees for a morning of celebration.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: